Advisory Board

Hon. Randall R. Rader (ret.),
Former Chief Judge, United States Court of Appeals for the Federal Circuit

Dr. GVS Sesha Kumar
Vice President & Head-Intellectual Property, Innovation, Dr. Reddy’s Laboratories
Dr. G V S Sesha Kumar, with over two decades of expertise in managing Intellectual Property in the pharmaceutical industry, holds a Ph.D. in chemistry, an LL.B, and an LL.M in IP law. His strategic acumen has resulted in multimillion-dollar IP wealth across various programs and territories. Sesha focuses on sustainable IP-driven business growth within the pharmaceutical, nutraceutical, and digital therapeutic sectors. His endeavours safeguard Dr. Reddy’s innovation across expanding frontiers while advancing global healthcare.

Dr. Pushpendra Rai
IAS, Former Director WIPO

Shashank Upadhye
Managing Partner, Upadhye Tang LLP
Shashank Upadhye is a recognized leader in the drug development IP/FDA law. He was chief in-house IP/FDA counsel at three leading pharmaceutical and medical device companies. He published 100+ articles, presented at 200+ conferences, and is the sole author of the leading pharma patent infringement and FDA book: Generic Pharmaceutical Patent & FDA Law, now in its 15th Edition (2023-2024).

Dr. Sumesh Reddy
Chief Global IP Counsel, Cipla
Dr. Sumesh Reddy is currently the Global Head of Intellectual Property for Cipla Ltd., a Mumbai-based multinational Indian pharmaceutical company. He has been with Cipla since 2015. Prior to joining Cipla, he was senior vice president for Mylan and a member of their core global patent group, responsible for all strategic decision-making related to IP. He has also worked as Senior Director for Dr. Reddy’s Laboratories between 2002-2013 and has been involved with Hatch-Waxman litigation since the early 2000’s. He was one of the founding members of Dr. Reddy’s IP function.